- Podium presentation at the American Head and Neck Society (AHNS) 12th International Conference on

Alpha Tau Medical Ltd. (NASDAQ: DRTS - Get Free Report) shares rose 7.1% on Friday. The company trad

Gainers Jasper Therapeutics (NASDAQ:JSPR) stock moved upwards by 19.2% to $0.92 during Friday's

Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell

AMPX, DRTS and BELFB have been added to the Zacks Rank #5 (Strong Sell) List on July 7, 2026.

DRTS, CANG and LAZ have been added to the Zacks Rank #5 (Strong Sell) List on July 2, 2026.

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan

Alpha Tau Medical Ltd. (NASDAQ:DRTS, DRTSW)) ("Alpha Tau"), the developer of the innovative

Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with

Alpha Tau Medical (DRTS) is pioneering localized alpha particle radiation for solid tumors, with str

Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Trial and Add Two U.S. Sites; Earl

Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY

- Joint partnership leverages Alpha Tau's highly potent, localized alpha-radiation technology and To

- Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally inva

Alpha Tau Medical NASDAQ: DRTS outlined a series of clinical and regulatory updates during the Lytha

- Groundbreaking interim results from U.S. REGAIN trial in recurrent glioblastoma demonstrate 100% l

JERUSALEM, May 18, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (

Shares of Alpha Tau Medical Ltd. (NASDAQ:DRTS) rose Monday after the company reported interim result

Alpha Tau Medical NASDAQ: DRTS presented early clinical results from the first three patients treate

- Interim results from the first three brain cancer patients treated; two of whom demonstrated compl

JERUSALEM, May 08, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd . (Nasdaq: DRTS, DRTSW) ("Alpha Ta

- First U.S. pivotal study for Alpha Tau to have completed enrollment, representing a critical miles

First patient ever treated with Alpha DaRT for pancreatic cancer in Italy, under a clinical study co

  On Thursday, 241 companies hit new 52-week lows.

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday a

  On Wednesday, 807 companies reached new 52-week lows.